Evidence map›Paper›PMID 37405542›Full record

ArticleNeurogenetics2023

Novel potentially pathogenic variants detected in genes causing intellectual disability and epilepsy in Polish families.

S Skoczylas, P Jakiel, T Płoszaj, K Gadzalska, M Borowiec, A Pastorczak, H Moczulska, M Malarska, A Eckersdorf-Mastalerz, E Budzyńska and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neurogenetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

S Skoczylas *1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland. sebastian.skoczylas@umed.lodz.pl.ORCID 0000-0003-2760-2397
P Jakiel *1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
T Płoszaj1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
K Gadzalska1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
M Borowiec1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
A Pastorczak1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
H Moczulska1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
M Malarska1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
A Eckersdorf-Mastalerz1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
E Budzyńska1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
A Zmysłowska1Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntellectual disability (ID) affects 1-3% of the world population. The number of genes whose dysfunctions cause intellectual disability is increasing. In addition, new gene associations are constantly being discovered, as well as specific phenotypic features for already identified genetic alterations are being described. The aim of our study was to search for pathogenic variants in genes responsible for moderate to severe intellectual disability and epilepsy, using a panel of targeted next-generation sequencing (tNGS) for diagnosis.

methodsThe group of 73 patients (ID, n=32; epilepsy, n=21; ID and epilepsy, n=18) was enrolled in the nucleus DNA (nuDNA) study using a tNGS panel (Agilent Technologies, USA). In addition, high coverage mitochondrial DNA (mtDNA) was extracted from the tNGS data for 54 patients.

resultsFifty-two rare nuDNA variants, as well as 10 rare and 1 novel mtDNA variants, were found in patients in the study group. The 10 most damaging nuDNA variants were subjected to a detailed clinical analysis. Finally, 7 nuDNA and 1 mtDNA were found to be the cause of the disease.

conclusionsThis shows that still a very large proportion of patients remain undiagnosed and may require further testing. The reason for the negative results of our analysis may be a non-genetic cause of the observed phenotypes or failure to detect the causative variant in the genome. In addition, the study clearly shows that analysis of the mtDNA genome is clinically relevant, as approximately 1% of patients with ID may have pathogenic variant in mitochondrial DNA.

Indexed as

EpilepsyIntellectual DisabilityDNA, MitochondrialHumansMutationPolandDNA, MitochondrialEpilepsyIntellectual disabilityNext-generation sequencingPathogenic variants

Identifiers

PMID37405542
PMCPMC10545623
OpenAlexW4383187356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.